Loading…
Danaher Corporation is projected to rise to $241.23 by 2027, a +21% move from its current price of $199.05. DHR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $195.89 | $199.17 | $202.51 | +0.06% |
| Jul 14 | $194.66 | $199.29 | $204.03 | +0.12% |
| Jul 15 | $193.75 | $199.41 | $205.23 | +0.18% |
| Jul 16 | $193.00 | $199.52 | $206.27 | +0.24% |
| Jul 17 | $192.36 | $199.64 | $207.20 | +0.30% |
| Jul 18 | $191.79 | $199.76 | $208.06 | +0.36% |
| Jul 19 | $191.28 | $199.88 | $208.87 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $191.28 | $199.88 | $208.87 | +0.42% |
| Week 2 | $188.61 | $200.71 | $213.59 | +0.84% |
| Week 3 | $186.77 | $201.55 | $217.50 | +1.26% |
| Week 4 | $185.35 | $202.39 | $221.00 | +1.68% |
| Week 5 | $184.20 | $203.23 | $224.23 | +2.10% |
| Week 6 | $183.24 | $204.08 | $227.29 | +2.53% |
| Week 7 | $182.42 | $204.93 | $230.22 | +2.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.
The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
Danaher (DHR) is a diversified, healthcare-focused company with a market position in professional, medical, research, and industrial products and services. The stock is currently priced and tracked within a broad healthcare equipment and diagnostic landscape.
As of now, the price sits at $197.93 with a market cap of $140.09B and a rank of 110. This places the group among sizable healthcare-and-life-sciences players with a substantial enterprise value.
The latest price outlook shows a path of earnings and revenue growth reflected in the year-by-year forecast, advancing from a neutral stance in 2026 to pronounced bullish momentum into the 2030s and beyond, with substantial upside projected by 2040 and 2050.
A major floor 18.7% below — a decisive break under it would weaken the trend.
The nearest floor, 11.5% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 7.7% above — clearing it would confirm fresh momentum.
Key DHR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DHR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $194.72 | Buy | $195.60 | Buy |
| MA 10 | $194.47 | Buy | $193.50 | Buy |
| MA 20 | $188.11 | Buy | $189.83 | Buy |
| MA 50 | $180.16 | Buy | $186.25 | Buy |
| MA 100 | $187.50 | Buy | $190.14 | Buy |
| MA 200 | $204.04 | Sell | $197.67 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.56 | Neutral |
| Stoch RSI (14) | 73.98 | Neutral |
| CCI (20) | 104.99 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.63 | Buy |
| ROC (12) | 11.22 | Buy |
| Bollinger %B (20,2) | 0.86 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.32 | Buy |
| Awesome (5,34) | 10.09 | Buy |
| Ultimate (7,14,28) | 67.94 | Neutral |
| Momentum (10) | 5.84 | Buy |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 195.16 | Buy |
| ADX (14) | 19.70 | Neutral |
| ATR (14) | 3.12 | Info |
The 30-day technical picture is bullish, supported by momentum and price action. RSI14 is 70, signaling renewed buying interest.
The stock sits between key moving averages, with SMA50 at $178.68 and SMA200 at $203.99. Near-term support is at $171.12 and resistance at $197.93. The 30-day price range runs from a low of $177.02 to a high of $221.31, highlighting a constructive, though volatile, trading window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $161.91 | $199.05 | $272.33 | 0% | Neutral | |
| $197.56 | $241.23 | $307.96 | +21% | Bullish | |
| $210.46 | $261.81 | $343.27 | +32% | Bullish | |
| $225.42 | $284.74 | $381.28 | +43% | Bullish | |
| $228.43 | $292.44 | $398.65 | +47% | Bullish | |
| $250.22 | $324.25 | $448.99 | +63% | Bullish | |
| $282.01 | $369.57 | $519.03 | +86% | Bullish | |
| $315.77 | $418.18 | $594.89 | +110% | Bullish | |
| $352.55 | $471.52 | $678.79 | +137% | Bullish | |
| $346.63 | $467.99 | $681.21 | +135% | Bullish | |
| $512.87 | $722.21 | $1,101.65 | +263% | Bullish | |
| $806.48 | $1,217.99 | $1,991.53 | +512% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $161.91 | $199.05 | $242.12 | +0.00% |
| August 2026 | $178.00 | $208.38 | $249.26 | +4.69% |
| September 2026 | $178.64 | $210.14 | $253.31 | +0.84% |
| October 2026 | $184.27 | $217.64 | $264.08 | +3.57% |
| November 2026 | $188.70 | $223.65 | $272.86 | +2.76% |
| December 2026 | $186.78 | $222.08 | $272.33 | -0.70% |
Click any year to see its month-by-month DHR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect DHR to range from $161.91 to $272.33 through 2026. The $199.05 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The DHR price prediction for 2027 points to an average of $241.23 (low $197.56, high $307.96) — a potential gain of +21% on today's $199.05. Momentum favours further upside here.
In 2028, DHR is projected to trade between $210.46 and $343.27, averaging $261.81 — a potential gain of +32% from today's $199.05. That is up +9% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Danaher Corporation's 2029 outlook centres on $284.74, within a $225.42 to $381.28 range. That is up +9% on the projected 2028 average. That marks a +43% change versus current levels. Momentum favours further upside here.
By 2030, DHR could reach as high as $398.65, with a base case around $292.44 and support toward $228.43 — roughly +47% from $199.05. Buyers look set to stay in control over this stretch.
Expect DHR to range from $250.22 to $448.99 through 2031. The $324.25 average target implies a +63% move from current prices. That is up +11% on the projected 2030 average. Momentum favours further upside here.
The DHR price prediction for 2032 points to an average of $369.57 (low $282.01, high $519.03) — a potential gain of +86% on today's $199.05. Buyers look set to stay in control over this stretch.
In 2033, DHR is projected to trade between $315.77 and $594.89, averaging $418.18 — a potential gain of +110% from today's $199.05. That is up +13% on the projected 2032 average. Momentum favours further upside here.
Danaher Corporation's 2034 outlook centres on $471.52, within a $352.55 to $678.79 range. That is up +13% on the projected 2033 average. That marks a +137% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, DHR could reach as high as $681.21, with a base case around $467.99 and support toward $346.63 — roughly +135% from $199.05. Momentum favours further upside here.
Expect DHR to range from $512.87 to $1,101.65 through 2040. The $722.21 average target implies a +263% move from current prices. That is up +54% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The DHR price prediction for 2050 points to an average of $1,217.99 (low $806.48, high $1,991.53) — a potential gain of +512% on today's $199.05. Momentum favours further upside here.
Investing $1,000 in DHR today (≈ 5.023863 DHR) could be worth
$6,118.99
+$5,118.99 (+512%) by 2050 · US Dollar
Based on the average projected DHR price of $1,217.99 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DHRwould be worth at today's price.
$1,000 invested in DHR on Jul 10, 2025 (≈ 4.865943 DHR) would be worth
$968.57
-$31.43 (-3.1%) today · 0.97× · US Dollar
Based on a DHR entry price of $205.51 vs. today's $199.05.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $197.93 | $1,005.66 | +0.6% |
| 1 month ago | $183.63 | $1,083.97 | +8.4% |
| 3 months ago | $189.61 | $1,049.79 | +5.0% |
| 6 months ago | $239 | $832.85 | -16.7% |
| 1 year ago | $205.51 | $968.57 | -3.1% |
| All time (5.0y) ago | $245.35 | $811.3 | -18.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DHR forecast.
Our base-case forecast reaches $400.00 around 2033.
Implied market cap at $400.00: $283.11B
The multi-year forecast shows a clear path of upside, with notable strength in the latter years. For 2026 the average forecast price is $197.93, with a min of $161.91, a max of $269.95 and a 0% ROI (neutral sentiment).
From 2027 onward, the outlook turns bullish with rising averages and meaningful ROIs: 2027 avg $239.61 (ROI 21.1%), 2028 avg $258.01 (ROI 30.4%), 2029 avg $278.96 (ROI 40.9%), and 2030 avg $286.86 (ROI 44.9%). The trend continues through 2031–2035 with higher averages and stronger ROIs, reaching 2035 avg $449.72 (ROI 127.2%).
The forecast escalates significantly in the 2040s and 2050s: 2040 avg $690.40 (ROI 248.8%), 2050 avg $1,150.52 (ROI 481.3%). These figures illustrate substantial long-term upside but remain estimates, not guarantees, and depend on market conditions, execution, and macro factors continuing to unfold as projected.
Tap a question to reveal the answer.
2030 forecast: avg $286.86, min $224.03, max $391.13, ROI 44.9%, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages and ROIs (2027 avg $239.61, ROI 21.1%; 2028 avg $258.01, ROI 30.4%; 2029 avg $278.96, ROI 40.9%; 2030 avg $286.86, ROI 44.9%). 2026 is neutral (avg $197.93, ROI 0%), indicating some near-term uncertainty. These are estimates, not guarantees.
The 2050 forecast max is $1,881.38, with an average of $1,150.52 and ROI 481.3%.
Current price is $197.93 and market cap is $140.09B.
The 30-day range is $177.02 to $221.31.
Danaher Corporation Community Discussion
0Share your Danaher Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.